IMMUNO-COV™ – The Test for Antibodies that Block SARS-CoV-2 Infection Read More

October 1-4, 2016

The 10th International Meeting on Replicating Oncolytic Virus Therapeutics

Kah-Whye Peng, PhD, CTO of Vyriad gave a Plenary presentation entitled “Vesicular stomatitis virus (VSV) as an oncolytic agent”. Stephen J. Russell, MD, PhD, CEO & President of Vyriad gave a Plenary presentation entitled “Measles as a versatile oncolytic agent”.

Visit event site

Media Inquiries

For inquiries, please contact mediarelations@vyriad.com